Pushko P, Sallberg M, Borisova G, Ruden U, Bichko V, Wahren B, Pumpens P, Magnius L
Biomedical Research and Study Center, Latvian University, Riga.
Virology. 1994 Aug 1;202(2):912-20. doi: 10.1006/viro.1994.1413.
Hepatitis B virus (HBV) core antigen (HBcAg) particles purified from Escherichia coli were probed in a competition enzyme immunoassay (EIA) with a panel of 16 murine monoclonal antibodies (MAbs) directed to different forms of core protein. The linear binding sites of the MAbs were mapped by combination of solid-phase and competition EIA using synthetic peptides covering the complete sequence of HBV core protein. Relative accessibilities of the linear binding sites at the HBcAg surface were investigated by comparing reactivities in solution of the MAbs to (i) two genetic variants of particulate HBcAg, (ii) denatured core protein, and (iii) synthetic peptides mimicking the appropriate linear binding sites. Further, accessibilities of HBV preS1 and preS2 epitopes (introduced into core protein at positions 77 or 144) at the surface of chimeric HBcAg particles were investigated. The previously described surface localization of core protein region 78-83 at the core particle surface was confirmed. In addition, another region, encompassing residues 127-133, was found to occupy a surface position at particulate HBcAg, whereas regions 9-20 and 133-145 were exposed after denaturation of the core protein and at synthetic peptides but not at particulate HBcAg.
从大肠杆菌中纯化的乙肝病毒(HBV)核心抗原(HBcAg)颗粒,在竞争酶免疫测定(EIA)中与一组针对不同形式核心蛋白的16种鼠单克隆抗体(MAb)进行检测。利用覆盖HBV核心蛋白完整序列的合成肽,通过固相和竞争EIA相结合的方法,绘制了单克隆抗体的线性结合位点。通过比较单克隆抗体与以下物质在溶液中的反应性,研究了HBcAg表面线性结合位点的相对可及性:(i)颗粒状HBcAg的两种基因变体,(ii)变性核心蛋白,以及(iii)模拟适当线性结合位点的合成肽。此外,还研究了嵌合HBcAg颗粒表面HBV preS1和preS2表位(在第77或144位引入核心蛋白)的可及性。先前描述的核心蛋白78 - 83区域在核心颗粒表面的定位得到了证实。此外,发现另一个包含127 - 133位残基的区域在颗粒状HBcAg上占据表面位置,而9 - 20和133 - 145区域在核心蛋白变性后以及合成肽上暴露,但在颗粒状HBcAg上不暴露。